Published in Int Immunol on February 01, 1995
IgM, Fc mu Rs, and malarial immune evasion. J Immunol (2010) 0.92
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood (1999) 11.57
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest (1998) 3.96
Ia-bearing T lymphocytes in man. Their identification and role in the generation of allogeneic helper activity. J Exp Med (1978) 3.18
Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol (2000) 3.13
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum (2002) 2.45
Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med (1978) 2.39
Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med (1989) 2.16
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors. J Exp Med (1979) 1.98
Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J Intern Med (2008) 1.95
Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem (1988) 1.80
T cell helper defect in patients with chronic lymphocytic leukemia. J Immunol (1979) 1.74
Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol (2000) 1.64
Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev (1979) 1.53
Effect of intravascular volume expansion on renal function during prolonged CO2 pneumoperitoneum. Ann Surg (2000) 1.41
Hapten-specific IgE antibody responses in mice. VII. Conversion of IgE "non-responder" strains to IgE "responders" by elimination of suppressor T cell activity. J Immunol (1977) 1.40
Conversion of systemic lupus erythematosus to common variable hypogammaglobulinemia. Am J Med (1989) 1.40
Hapten-specific IgE antibody responses in mice. VI. Selective enhancement of IgE antibody production by low doses of X-irradiation and by cyclophosphamide. J Immunol (1976) 1.36
Structural basis of DNA bending and oriented heterodimer binding by the basic leucine zipper domains of Fos and Jun. Proc Natl Acad Sci U S A (1997) 1.34
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2. Leukemia (2013) 1.31
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia (2009) 1.27
Helper factors derived from autologous mixed lymphocyte cultures. Cell Immunol (1980) 1.26
Immunoglobulin heavy chain variable region gene replacement As a mechanism for receptor revision in rheumatoid arthritis synovial tissue B lymphocytes. J Exp Med (2000) 1.25
Regulation of the immune response by sex hormones. I. In vitro effects of estradiol and testosterone on pokeweed mitogen-induced human B cell differentiation. J Immunol (1988) 1.21
Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J Clin Invest (1979) 1.19
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients. J Pharmacol Exp Ther (1989) 1.16
Monoclonal antibodies with specificity for hairy cell leukemia cells. J Clin Invest (1982) 1.15
Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Immunopathol (1982) 1.15
Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor. J Exp Med (1985) 1.15
T cell antigen receptors in autoimmunity. J Immunol (1988) 1.11
Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol (1997) 1.10
Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med (1986) 1.10
Induction of human antibody responses in vitro with emphasis on allogeneic helper factors. Immunol Rev (1979) 1.09
Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas. J Exp Med (1982) 1.09
Regulation of IgE antibody production by serum molecules. I. Serum from complete Freund's adjuvant-immune donors suppresses irradiation-enhanced IgE production in low responder mouse strains. J Immunol (1978) 1.06
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res (1995) 1.06
Clonal expansion is a characteristic feature of the B-cell repetoire of patients with rheumatoid arthritis. Arthritis Res (2000) 1.03
Immunoglobulin V region gene use and structure suggest antigen selection in AIDS-related primary effusion lymphomas. Leukemia (1999) 1.01
Human B cell activation. Evidence for diverse signals provided by various monoclonal anti-IgM antibodies. J Exp Med (1985) 1.01
Induction of T cell-dependent B cell differentiation by anti-CD3 monoclonal antibodies. J Immunol (1987) 1.01
CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood (1990) 1.00
Molecular basis of cooperative DNA bending and oriented heterodimer binding in the NFAT1-Fos-Jun-ARRE2 complex. Proc Natl Acad Sci U S A (1998) 1.00
Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum (1985) 0.99
Affinity requirements for induction of sequential phases of human B cell activation by membrane IgM-cross-linking ligands. J Immunol (1991) 0.98
T cell antiidiotypic antibodies reveal differences between two human leukemias. J Exp Med (1984) 0.97
In vivo and post mortem dissolution rates of pulmonary emboli and venous thrombi in the dog. Circulation (1973) 0.97
Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood (1996) 0.97
Hapten specific IgE antibody responses in mice. V. Differential resistance of IgE and IgG B lymphocytes to X-irradiation. J Immunol (1976) 0.96
Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition. J Immunol (1999) 0.95
Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant (1998) 0.95
Highly heterogeneous nature of delta-aminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria. Blood (2001) 0.95
Regulatory role of circulating monocytes in the differentiative and proliferative responses of human B lymphocytes. Clin Immunol Immunopathol (1980) 0.94
A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol (1994) 0.94
Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest (1996) 0.94
Methicillin-resistant Staphylococcal enterocolitis. Am J Med (1998) 0.94
Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood (1996) 0.94
Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience. Ann Surg (1996) 0.93
Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes. J Immunol (1984) 0.93
S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol (1988) 0.91
Induction if immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy. Proc Natl Acad Sci U S A (1976) 0.90
Familial systemic lupus erythematosus in males. Arthritis Rheum (1983) 0.90
Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation. J Immunol (1992) 0.90
An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. J Immunol (1984) 0.89
Deleterious effect of waiting time on renal transplant outcome. Transplant Proc (2001) 0.86
Subepithelial B cells in the human palatine tonsil. I. Morphologic, cytochemical and phenotypic characterization. Eur J Immunol (1996) 0.86
Expression of CD5 and CD38 by human CD5- B cells: requirement for special stimuli. Eur J Immunol (1994) 0.86
Simultaneous flow cytometric analysis of cell surface markers and telomere length: analysis of human tonsilar B cells. J Immunol Methods (2001) 0.86
Lack of intraclonal diversification in Ig heavy and light chain V region genes expressed by CD5+IgM+ chronic lymphocytic leukemia B cells: a multiple time point analysis. J Immunol (1998) 0.86
Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors. J Cancer Res Clin Oncol (1990) 0.86
Biased usage of variable and constant-region Ig genes by IgG+, CD5+ human leukemic B cells. Ann N Y Acad Sci (1992) 0.86
Naturally occurring antibodies reactive with sperm proteins: apparent deficiency in AIDS sera. Science (1985) 0.84
What is the CLL B-lymphocyte? Leuk Lymphoma (1996) 0.84
Long-term pulmonary blood flow alterations following relief of partial bronchial obstruction. Am J Med (1974) 0.84
Immunological properties of conjugates of ragweed pollen antigen E with methoxypolyethylene glycol or a copolymer of D-glutamic acid and D-lysine. J Exp Med (1979) 0.83
Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens. Eur J Immunol (1991) 0.82
Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes. Leukemia (2000) 0.82
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome. Arthritis Rheum (1999) 0.82
Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation (2001) 0.81
Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation (2000) 0.81
Description and partial characterization of a nucleolar RNA-associated autoantigen defined by a human monoclonal antibody. J Exp Med (1987) 0.81
Serial phenotypic, cytogenetic and molecular genetic studies in Richter's syndrome: demonstration of lymphoma development from the chronic lymphocytic leukaemia cells. Br J Haematol (1993) 0.81
Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations. J Immunol (1989) 0.81
The human Ig-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes. J Immunol (1993) 0.81
VH gene usage by family members affected with chronic lymphocytic leukaemia. Br J Haematol (1999) 0.81
Subepithelial B cells in the human palatine tonsil. II. Functional characterization. Eur J Immunol (1996) 0.81
Interaction between anti-DNA and anti-DNA-binding protein autoantibodies in cryoglobulins from sera of patients with systemic lupus erythematosus. J Exp Med (1986) 0.81
Outcomes of pediatric living donor renal transplant after laparoscopic versus open donor nephrectomy. Transplant Proc (2002) 0.81
Biochemical characterization and purification of human B cell stimulatory factor (BSF). Eur J Immunol (1985) 0.80
Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation. Curr Top Microbiol Immunol (2000) 0.80
Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol (1995) 0.80
Induction of a ragweed-specific allergic state in Ir-gene-restricted nonresponder mice. J Exp Med (1977) 0.80
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc (2005) 0.80
The complete sequence of the human CD79b (Ig beta/B29) gene: identification of a conserved exon/intron organization, immunoglobulin-like regulatory regions, and allelic polymorphism. Immunogenetics (1994) 0.79
Human B cell activation. Effect of T cell cytokines on the physicochemical binding requirements for achieving cell cycle progression via the membrane IgM signaling pathway. J Immunol (1995) 0.79
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin. Transplantation (1996) 0.79